Massachusetts
|
04-2911026
|
State
or Other Jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
Incorporation
or Organization)
|
Class
|
Number
of Shares Outstanding
|
Common
Stock, par value $0.01 per share
|
23,781,820
shares
|
Page
|
||
PART
I
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Unaudited
Consolidated Financial Statements
|
|
Consolidated
Balance Sheets as of September 30, 2007 and December 31,
2006
|
3
|
|
Consolidated
Statements of Operations for the Three and Nine Months Ended September
30,
2007 and September 30, 2006
|
4
|
|
Consolidated
Statements of Cash Flows for the Nine Months Ended September 30,
2007 and
September 30, 2006
|
5
|
|
Notes
to Consolidated Financial Statements
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
10
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
15
|
Item
4.
|
Controls
and Procedures
|
16
|
PART
II
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
16
|
Item
1A.
|
Risk
Factors
|
17
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use Of Proceeds
|
26
|
Item
6.
|
Exhibits
|
27
|
Signatures
|
27
|
September
30,
2007
|
December
31,
2006
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash
equivalents
|
$ |
4,807
|
$ |
8,571
|
||||
Short-term
investments
|
32,848
|
29,263
|
||||||
Accounts
receivable,
net
|
7,697
|
4,738
|
||||||
Inventories
|
1,423
|
819
|
||||||
Prepaid
expenses and other current
assets
|
690
|
867
|
||||||
Total
current
assets
|
47,465
|
44,258
|
||||||
Property
and equipment,
net
|
8,022
|
8,123
|
||||||
Investments
|
492
|
1,968
|
||||||
Other
assets,
net
|
186
|
237
|
||||||
Total
assets
|
$ |
56,165
|
$ |
54,586
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ |
1,146
|
$ |
692
|
||||
Accrued
expenses
|
130
|
153
|
||||||
Accrued
compensation
|
1,474
|
1,043
|
||||||
Accrued
professional
|
179
|
198
|
||||||
Deferred
revenue
|
359
|
800
|
||||||
Total
current
liabilities
|
3,288
|
2,886
|
||||||
Long-term
deferred
revenue
|
330
|
330
|
||||||
Stockholders’
equity:
|
||||||||
Preferred
stock, $1.00 par value; 1,000,000 shares authorized,
none
outstanding
|
-
|
-
|
||||||
Common
stock, $.01 par value; 70,000,000 shares authorized; issued
and
outstanding, 23,775,720 as of September 30, 2007 and
23,642,753
as
of December 31, 2006
|
238
|
236
|
||||||
Additional
paid-in
capital
|
83,130
|
81,923
|
||||||
Accumulated
deficit
|
(30,821 | ) | (30,789 | ) | ||||
Total
stockholders’ equity
|
52,547
|
51,370
|
||||||
Total
liabilities and stockholders’
equity
|
$ |
56,165
|
$ |
54,586
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2007
|
2006
|
2007
|
2006
|
|||||||||||||
Revenue:
|
||||||||||||||||
Product
sales
|
$ |
5,097
|
$ |
1,736
|
$ |
12,333
|
$ |
4,973
|
||||||||
Contract
revenue
|
1,851
|
3,990
|
5,260
|
9,924
|
||||||||||||
Royalties
|
508
|
956
|
2,092
|
2,710
|
||||||||||||
Total
revenue
|
7,456
|
6,682
|
19,685
|
17,607
|
||||||||||||
Costs
and expenses:
|
||||||||||||||||
Cost
of product sales
|
901
|
286
|
3,087
|
615
|
||||||||||||
Cost
of contract revenue
|
1,553
|
1,363
|
4,315
|
3,759
|
||||||||||||
Research
and development
|
2,528
|
2,602
|
7,735
|
8,200
|
||||||||||||
Selling
and marketing
|
936
|
784
|
2,808
|
2,518
|
||||||||||||
General
and administrative
|
1,009
|
964
|
3,269
|
3,354
|
||||||||||||
Total
costs and
expenses
|
6,927
|
5,999
|
21,214
|
18,446
|
||||||||||||
Income/(loss)
from operations
|
529
|
683
|
(1,529 | ) | (839 | ) | ||||||||||
Interest
income
|
512
|
490
|
1,520
|
1,342
|
||||||||||||
Income/(loss)
before provision for income taxes
|
1,041
|
1,173
|
(9 | ) |
503
|
|||||||||||
Provision
for income taxes
|
6
|
333
|
23
|
352
|
||||||||||||
Net
income/(loss)
|
$ |
1,035
|
$ |
840
|
$ | (32 | ) | $ |
151
|
|||||||
Net
income/(loss) per share – basic
|
$ |
0.04
|
$ |
0.04
|
$ | (0.00 | ) | $ |
0.01
|
|||||||
Net
income/(loss) per share – diluted
|
$ |
0.04
|
$ |
0.03
|
$ | (0.00 | ) | $ |
0.01
|
|||||||
Weighted
average shares – basic
|
23,757
|
23,552
|
23,710
|
23,433
|
||||||||||||
Weighted
average shares - diluted
|
24,996
|
24,987
|
23,710
|
24,976
|
Nine
Months Ended
|
||||||||
September
30,
|
||||||||
2007
|
2006
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
income
(loss)
|
$ | (32 | ) | $ |
151
|
|||
Adjustments
to reconcile net income (loss) to net cash
provided
by (used in) operating activities:
|
||||||||
Depreciation
and
amortization
|
652
|
491
|
||||||
Stock
based
compensation
|
792
|
1,694
|
||||||
Increase
(decrease) from changes in assets and liabilities:
|
||||||||
Accounts
receivable
|
(2,959 | ) | (2,106 | ) | ||||
Inventories
|
(604 | ) | (666 | ) | ||||
Prepaid
expenses
|
177
|
17
|
||||||
Accounts
payable
|
454
|
(151 | ) | |||||
Accrued
expenses
|
389
|
567
|
||||||
Deferred
revenue
|
(441 | ) |
551
|
|||||
Net
cash provided by (used in) operating activities
|
(1,572 | ) |
548
|
|||||
Cash
flows from investing activities:
|
||||||||
Purchases
of property and
equipment
|
(500 | ) | (301 | ) | ||||
Sales
of
investments
|
18,338
|
14,031
|
||||||
Purchases
of investments
|
(20,447 | ) | (15,316 | ) | ||||
Net
cash used in investing activities
|
(2,609 | ) | (1,586 | ) | ||||
Cash
flows from financing activities:
|
||||||||
Proceeds
from issuance of common
stock
|
455
|
649
|
||||||
Repurchase
of common
stock
|
(38 | ) |
-
|
|||||
Net
cash provided by financing activities
|
417
|
649
|
||||||
Decrease
in cash and cash
equivalents
|
(3,764 | ) | (389 | ) | ||||
Cash
and cash equivalents, beginning of period
|
8,571
|
13,068
|
||||||
Cash
and cash equivalents, end of
period
|
$ |
4,807
|
$ |
12,679
|
A)
|
Basis
of Presentation
|
The
accompanying unaudited consolidated balance sheet, statements of
operations, and statements of cash flows reflect all adjustments
(consisting only of normal recurring items) which are, in the opinion
of
management, necessary for a fair presentation of financial position
at
September 30, 2007, and of operations and cash flows for the interim
periods ended September 30, 2007 and 2006. Certain reclassifications
have
been made to the prior year financial statements to conform to the
current
year presentation.
|
|
The
accompanying unaudited consolidated financial statements have been
prepared in accordance with the instructions for Form 10-Q and therefore
do not include all information and footnotes necessary for a complete
presentation of our financial position, results of operations and
cash
flows, in conformity with generally accepted accounting
principles. The Company filed audited financial statements
which included all information and footnotes necessary for such
presentation for the three years ended December 31, 2006 in conjunction
with our 2006 Annual Report on Form 10-K.
|
|
The
results of operations for the interim period ended September 30,
2007 are
not necessarily indicative of the results to be expected for the
year.
|
|
B)
|
Inventory
|
Inventories
are stated at the lower of cost or market with cost being determined
by
the first-in, first-out (“FIFO”) method. Inventory reserves are
established for estimated excess and obsolete
inventory.
|
September
30,
2007
|
December
31,
2006
|
|||||||
Raw
materials
|
$ |
1,423
|
$ |
819
|
C)
|
Computation
of Earnings per Share
|
Basic
earnings per share is
computed by dividing net income or loss by the weighted average number
of
common shares outstanding. Diluted earnings per share is
computed by dividing net income or loss by the weighted average number
of
common shares outstanding plus additional common shares that would
have
been outstanding if dilutive potential common shares had been
issued. For the purposes of this calculation, stock options are
considered common stock equivalents in periods in which they have
a
dilutive effect. Stock options that are anti-dilutive are
excluded from the calculation.
|
|
Net
income or loss per share is calculated as follows (in thousands,
except
per share data):
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2007
|
2006
|
2007
|
2006
|
|||||||||||||
Net
income (loss)
|
$ |
1,035
|
$ |
840
|
$ | (32 | ) | $ |
151
|
|||||||
Weighted
average common shares outstanding
|
23,757
|
23,552
|
23,710
|
23,433
|
||||||||||||
Additional
dilutive common stock equivalents
|
1,239
|
1,435
|
-
|
1,543
|
||||||||||||
Diluted
shares outstanding
|
24,996
|
24,987
|
23,710
|
24,976
|
||||||||||||
Net
income (loss) per share – basic
|
$ |
0.04
|
$ |
0.04
|
$ | (0.00 | ) | $ |
0.01
|
|||||||
Net
income (loss) per share – diluted
|
$ |
0.04
|
$ |
0.03
|
$ | (0.00 | ) | $ |
0.01
|
For
the nine month period ended September 30, 2007 potential common stock
equivalents of 1,423,513 were not included in the per share calculation
for diluted EPS, because we had net losses and the effect of their
inclusion would be anti-dilutive. For the three month periods
ended September 30, 2007 and 2006, options to purchase 3,173,175
and
2,441,742 shares of common stock, respectively, were outstanding,
but were
not included in the computation of diluted EPS because the options’
exercise prices were greater than the average market price of the
common
stock and thus would be anti-dilutive. For the nine month
periods ended September 30, 2007 and 2006, options to purchase 2,420,025
and 2,415,492 shares of common stock, respectively, were outstanding,
but
were not included in the computation of diluted EPS because the options’
exercise prices were greater than the average market price of the
common
stock and thus would be anti-dilutive.
|
|
D)
|
Stock-Based
Compensation
|
|
|
The
following table presents stock-based employee compensation expense
included in the Company’s unaudited consolidated statements of operations
(in thousands):
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2007
|
2006
|
2007
|
2006
|
|||||||||||||
Cost
of product
sales
|
$ |
4
|
$ |
4
|
$ |
8
|
$ |
12
|
||||||||
Cost
of contract
revenue
|
54
|
13
|
133
|
98
|
||||||||||||
Research
and
development
|
127
|
241
|
311
|
786
|
||||||||||||
Selling
and
marketing
|
32
|
88
|
78
|
266
|
||||||||||||
General
and
administrative
|
88
|
106
|
262
|
532
|
||||||||||||
Stock-based
compensation
expense
|
$ |
305
|
$ |
452
|
$ |
792
|
$ |
1,694
|
The
Company estimates the fair value of stock options using the Black-Scholes
valuation model. This valuation model takes into account the exercise
price of the award, as well as a variety of significant assumptions.
These
assumptions used to estimate the fair value of stock options include
the
expected term, the expected volatility of the Company’s stock over the
expected term, the risk-free interest rate over the expected term,
and the
Company’s expected annual dividend yield. The Company believes that the
valuation technique and the approach utilized to develop the underlying
assumptions are appropriate
in calculating the fair values of the Company’s stock options granted in
the nine months ended September 30, 2007. Estimates of fair value are
not intended to predict actual future events or the value ultimately
realized by persons who receive equity awards.
|
|
|
E)
|
Business
Segments
|
The
Company organizes itself as one segment and conducts its operations
in the
United States.
|
|
The
Company sells its products and technology to domestic and international
customers. Revenues were generated from the following
geographic regions (in thousands):
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2007
|
2006
|
2007
|
2006
|
|||||||||||||
United
States
|
$ |
4,610
|
$ |
2,832
|
$ |
12,225
|
$ |
9,498
|
||||||||
Germany
|
1,534
|
1,111
|
4,274
|
4,613
|
||||||||||||
Rest
of
World
|
1,312
|
2,739
|
3,186
|
3,496
|
||||||||||||
$ |
7,456
|
$ |
6,682
|
$ |
19,685
|
$ |
17,607
|
F)
|
Income
Taxes
|
The
Company adopted the provisions of Financial Standards Accounting
Board
Interpretation No. 48 Accounting for Uncertainty in Income Taxes
(“FIN
48”) an interpretation of FASB Statement No. 109 (“SFAS 109”) on January
1, 2007. As a result of the implementation of FIN 48, the
Company recognized no material adjustment in the liability for
unrecognized income tax benefits. At the adoption date of
January 1, 2007 and also at September 30, 2007, the Company had no
unrecognized tax benefits.
|
|
The
Company recognizes interest and penalties related to uncertain tax
positions in income tax expense. As of September 30, 2007, the
Company had no accrued interest or penalties related to uncertain
tax
positions.
|
|
The
tax years 2003 through 2006 remain open to examination by the major
taxing
jurisdictions to which the Company is subject.
|
|
As
of December 31, 2006, the Company had federal net operating loss
and
research and experimentation credit carryforwards of approximately
$49.9
million and $11.4 million respectively, which may be available to
offset
future federal income tax liabilities and expire at various dates
from
2007 through 2026. In addition, at December 31, 2006, the
Company had approximately $8.3 million and $5.8 million of state
net
operating losses and state research and development and investment
tax
carryforwards, respectively, which expire at various dates from 2007
through 2021.
|
|
Utilization
of net operating loss and research and development credit carryforwards
may be subject to a substantial annual limitation due to ownership
change
limitations that have occurred previously or that could occur in
the
future provided by Section 382 of the Internal Revenue Code of 1986,
as
well as similar state provisions. These ownership changes may
limit the amount of net operating loss and research and development
credit
carryforwards that can be utilized annually to offset future taxable
income and tax, respectively. The Company has not currently
completed a study to assess whether a change of control has
occurred. Until a study is completed and any limitation known,
no amounts are being presented as an uncertain tax position under
FIN
48.
|
|
G)
|
Recent
Accounting Pronouncements
|
In
September 2006, the FASB issued Statement No. 157, “Fair Value
Measurements” (“SFAS 157”). The Statement provides
guidance for using fair value to measure assets and liabilities.
This Statement references fair value as the price that would be
received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants in the market in which the
reporting entity transacts. The Statement applies whenever other
standards
require (or permit) assets or liabilities to be measured at fair
value.
The Statement does not expand the use of fair value in any new
circumstances. It is expected to be effective for financial
statements issued for fiscal years beginning after November 15, 2007,
and
interim periods within those fiscal years. The adoption of SFAS 157
is not expected to have a material impact on the Company’s financial
position, results of operations or cash flows.
|
|
In
February 2007, the FASB issued Statement of Financial Accounting
Standards
No. 159, “The Fair Value Option for Financial Assets and Financial
Liabilities, including an amendment of FASB Statements No. 115”
(“SFAS 159”). SFAS 159 permits entities to choose, at specified
election dates, to measure eligible items at fair value (the “fair value
option”). A business entity shall report unrealized gains and losses on
items for which the fair value option has been elected in earnings
at each
subsequent reporting period. This accounting standard is effective
as of
the beginning of an entity’s first fiscal year that begins after
November 15, 2007. The effect, if any, of adopting SFAS 159 on
the Company’s financial position and results of operations has not been
finalized.
|
|
H)
|
Share
Repurchase Program
|
On
August 28, 2007, the Company announced a stock repurchase program
to
purchase up to $5 million of our common stock, subject to market
conditions and other factors. Any purchases under the Company’s stock
repurchase program may be made from time to time without prior notice.
The
authorization to repurchase Company stock expires on December 31,
2008. As
of September 30, 2007, the Company had repurchased 9,107 shares of
common stock under this program.
|
|
—
|
Cash
and cash equivalents, which consist of financial instruments with
original
maturities of three months or less; and
|
|
—
|
Investments,
which consist of financial instruments that meet the high quality
standards specified in our investment policy. This policy
dictates that all instruments mature in three years or less, and
limits
the amount of credit exposure to any one issue, issuer, and type
of
instrument.
|
Valuation
of securities
given
an interest rate
decrease
of
|
Valuation
of securities
given
an interest rate
increase
of
|
|||||||||||||||||||
Type
of security
|
(100BP)
|
(50
BP)
|
No
change
in
interest
rates
|
100
BP
|
50
BP
|
|||||||||||||||
Long-term
investments with
|
||||||||||||||||||||
maturities
of one to three years
|
$ |
499
|
$ |
496
|
$ |
492
|
$ |
485
|
$ |
489
|
·
|
market
acceptance of broadband technologies we supply by semiconductor
or equipment companies;
|
|
·
|
the
extent and timing of new license transactions with semiconductor
companies;
|
|
·
|
changes
in our and our licensees’ development schedules and levels of expenditure
on research and development;
|
|
·
|
the
loss of a strategic relationship or termination of a project by a
licensee;
|
|
·
|
equipment
companies' acceptance of integrated circuits produced by our
licensees;
|
|
·
|
the
loss by a licensee of a strategic relationship with an equipment
company
customer;
|
|
·
|
announcements
or introductions of new technologies or products by us or our
competitors;
|
·
|
delays
or problems in the introduction or performance of enhancements or
of
future generations of our technology;
|
|
·
|
failures
or problems in our hardware or software products;
|
|
·
|
price
pressure in the biometrics or test and diagnostics markets from our
competitors;
|
|
·
|
delays
in the adoption of new industry standards or changes in market perception
of the value of new or existing standards;
|
|
·
|
competitive
pressures resulting in lower contract revenues or royalty
rates;
|
|
·
|
competitive
pressures resulting in lower software or hardware product
revenues;
|
|
·
|
personnel
changes, particularly those involving engineering and technical
personnel;
|
|
·
|
costs
associated with protecting our intellectual property;
|
|
·
|
the
potential that licensees could fail to make payments under their
current
contracts;
|
|
·
|
ADSL
market-related issues, including lower ADSL chipset unit demand brought
on
by excess channel inventory and lower average selling prices for
ADSL
chipsets as a result of market surpluses;
|
|
·
|
VDSL
market-related issues, including lower VDSL chipset unit demand brought
on
by excess channel inventory and lower average selling prices for
VDSL
chipsets as a result of market surpluses;
|
|
·
|
hardware
manufacturing issues, including yield problems in our hardware platforms,
and inventory buildup and obsolescence;
|
|
·
|
product
gross margin may be affected by various factors including, but not
limited
to, product mix, product life cycle, and provision for excess and
obsolete
inventory.;
|
|
·
|
significant
fluctuations in demand for our hardware products;
|
|
·
|
regulatory
developments; and
|
|
·
|
general
economic trends and other factors.
|
·
|
the
semiconductor and telecommunications markets decline;
|
|
·
|
our
existing customers do not increase their revenues from sales of chipsets
with our technology;
|
|
·
|
new
or existing customers do not choose to license our intellectual property
for new chipset products; or
|
|
·
|
new
or existing customers do not choose to use our software or hardware
products.
|
·
|
we
must typically undergo a lengthy and expensive process of building
a
relationship with a potential licensee before there is any assurance
of a
license agreement with such party;
|
|
·
|
we
must persuade semiconductor and equipment manufacturers with significant
resources to rely on us for critical technology on an ongoing basis
rather
than trying to develop similar technology internally;
|
|
·
|
we
must persuade potential licensees to bear development costs associated
with our technology applications and to make the necessary investment
to
successfully manufacture chipsets and products using our technology;
and
|
|
·
|
we
must successfully transfer technical know-how to
licensees.
|
·
|
we
cannot obtain suitable licensees;
|
|
·
|
our
licensees fail to achieve significant sales of chipsets or products
incorporating our technology; or
|
|
·
|
we
otherwise fail to implement our business strategy
successfully.
|
·
|
competition
from other businesses in the same industry;
|
|
·
|
market
acceptance of its products;
|
|
·
|
its
engineering, sales and marketing, and management
capabilities;
|
|
·
|
technical
challenges of developing its products unrelated to our technology;
and
|
|
·
|
its
financial and other resources.
|
·
|
the
desire of telephone companies to install ADSL or VDSL service, which
is
dependent on the development of a viable business model for ADSL
or VDSL
service, including the capability to market, sell, install and maintain
the service;
|
|
·
|
the
pricing of ADSL or VDSL services by telephone
companies;
|
|
·
|
the
success of internet protocol TV (“IPTV”) or video-based services as viable
consumer service offerings;
|
|
·
|
the
transition by telephone companies to new ADSL technologies, such
as ADSL2,
ADSL2+ and VDSL2;
|
|
·
|
the
quality of telephone companies’ networks;
|
|
·
|
deployment
by phone companies of fiber-to-the-home or broadband wireless
services;
|
|
·
|
government
regulations; and
|
|
·
|
the
willingness of residential telephone customers to demand DSL service
in
the face of competitive service offerings, such as cable modems,
fiber-based service or broadband wireless
access.
|
—
|
market
acceptance of our biometric technologies and products;
|
|
—
|
changes
in contracting practices of government or law enforcement
agencies;
|
|
—
|
the
failure of the biometrics market to experience continued
growth;
|
|
—
|
announcements
or introductions of new technologies or products or our
competitors;
|
|
—
|
delays
or problems in the introduction or performance of enhancements or
of
future generations of our technology;
|
|
—
|
failures
or problems in our biometric software products;
|
|
—
|
delays
in the adoption of new industry biometric standards or changes in
market
perception of the value of new or existing standards;
|
|
—
|
growth
of proprietary biometric systems which do not conform to industry
standards;
|
|
—
|
competitive
pressures resulting in lower software product revenues;
|
|
—
|
personnel
changes, particularly those involving engineering, technical and
sales and
marketing personnel;
|
|
—
|
costs
associated with protecting our intellectual property;
|
|
—
|
litigation
by third parties for alleged infringement of their proprietary
rights;
|
|
—
|
the
potential that licensees could fail to make payments under their
current
contracts;
|
|
—
|
regulatory
developments; and
|
|
—
|
general
economic trends and other factors.
|
·
|
quarterly
fluctuations in our operating results;
|
|
·
|
changes
in future financial guidance that we may provide to investors and
public
market analysts;
|
|
·
|
changes
in our relationships with our licensees;
|
|
·
|
announcements
of technological innovations or new products by us, our licensees
or our
competitors;
|
|
·
|
changes
in DSL or biometrics market growth rates as well as investor perceptions
regarding the investment opportunity that companies participating
in the
DSL or biometrics industry afford them;
|
|
·
|
changes
in earnings estimates by public market analysts;
|
|
·
|
key
personnel losses;
|
|
·
|
sales
of our common stock; and
|
|
·
|
developments
or announcements with respect to industry standards, patents or
proprietary rights.
|
Period
|
|
(a)
Total
Number
of
Shares
Purchased
|
|
(b)
Average
Price
Paid
per
Share
|
|
(c)
Total
Number of
Shares
Purchased
as Part
of
Publicly
Announced
Plans
or
Programs(1)
|
(d)
Maximum
Number(or
Approximate
Dollar
Value)
of Shares that
May
Yet Be
Purchased
Under
the
Plans
or
Programs
|
|
|||
August
28, 2007 to August 30,
2007
|
|
-
|
|
|
|
|
|||||
September
1, 2007, to Sept. 30,
2007
|
|
9,107
|
$ |
4.19
|
|
9,107
|
$
|
4,961,830
|
Exhibit
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
Exhibit
31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
Exhibit
32.1
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to
Section
906 of the Sarbanes-Oxley Act of
2002.
|
AWARE,
INC.
|
||
Date:
November 8, 2007
|
By:
|
/s/
Michael A. Tzannes
|
Michael
A. Tzannes, Chief Executive Officer
|
||
Date:
November 8, 2007
|
By:
|
/s/
Keith E. Farris
|
Keith
E. Farris, Chief Financial Officer
(Principal
Financial and Accounting Officer)
|